Mycophenolate Mofetil recalled over manufacturing violations
- Recall date
- May 18, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Attix Pharmaceuticals Inc recalls Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or proc…
- Recall number
- D-1047-2016
- FDA classification
- Class III
- Brand / firm
- Attix Pharmaceuticals Inc
- Sold / distributed
- CO
Why it was recalled
cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix Pharmaceuticals, Toronto, Canada
Get recall alerts
Free email alert whenever Attix Pharmaceuticals Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Attix Pharmaceuticals Inc